Although the HIF-1α is the leading isoform in breast cancer, the HIF-2α isoform is a critical regulator of physiological and pathophysiological angiogenesis and, at least, similarly important to HIF-1α [89]. This evidence concerns the gene EPAS1 and breast carcinoma.